(Q33155566)

English

A phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory mantle cell lymphoma

scientific article

Statements

A phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory mantle cell lymphoma (English)
F Morschhauser
H C Kluin-Nelemans
M Pfreundschuh
J Raemaekers
M B van 't Veer
28 September 2007

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit